Targets and Mechanisms of Xuebijing in the Treatment of Acute Kidney Injury Associated with Sepsis: A Network Pharmacology-based Study


Cite item

Full Text

Abstract

Introduction:Sepsis is a state of the systemic inflammatory response of the host induced by infection, frequently affecting numerous organs and producing varied degrees of damage. The most typical consequence of sepsis is sepsis-associated acute kidney injury(SA-AKI). Xuebijing is developed based on XueFuZhuYu Decoction. Five Chinese herbal extracts, including Carthami Flos, Radix Paeoniae Rubra, Chuanxiong Rhizoma, Radix Salviae, and Angelicae Sinensis Radix, make up the majority of the mixture. It has properties that are anti-inflammatory and anti-oxidative stress. Xuebijing is an effective medication for the treatment of SA-AKI, according to clinical research. But its pharmacological mechanism is still not completely understood.

Methods:First, the composition and target information of Carthami Flos, Radix Paeoniae Rubra, Chuanxiong Rhizoma, Radix Salviae, and Angelicae Sinensis Radix were collected from the TCMSP database, while the therapeutic targets of SA-AKI were exported from the gene card database. To do a GO and KEGG enrichment analysis, we first screened the key targets using a Venn diagram and Cytoscape 3.9.1. To assess the binding activity between the active component and the target, we lastly used molecular docking.

Results:For Xuebijing, a total of 59 active components and 267 corresponding targets were discovered, while for SA-AKI, a total of 1,276 targets were connected. There were 117 targets in all that was shared by goals for active ingredients and objectives for diseases. The TNF signaling pathway and the AGE-RAGE pathway were later found to be significant pathways for the therapeutic effects of Xuebijing by GO analysis and KEGG pathway analysis. Quercetin, luteolin, and kaempferol were shown to target and modulate CXCL8, CASP3, and TNF, respectively, according to molecular docking results.

Conclusion:This study predicts the mechanism of action of the active ingredients of Xuebijing in the treatment of SA-AKI, which provides a basis for future applications of Xuebijing and studies targeting the mechanism.

About the authors

Jing Wang

Department of Blood Transfusion,, The Affiliated Hospital of Southwest Medical University

Author for correspondence.
Email: info@benthamscience.net

Chengyu Luo

Department of Clinical Medicine, Faculty of Clinical Medicine,, Southwest Medical University

Email: info@benthamscience.net

Mengling Luo

Department of Clinical Medicine, Faculty of Clinical Medicine,, Southwest Medical University

Email: info@benthamscience.net

Siwen Zhou

Department of Clinical Medicine, Faculty of Clinical Medicine, Southwest Medical University

Email: info@benthamscience.net

Guicheng Kuang

Department of Clinical Medicine, Faculty of Clinical Medicine, Southwest Medical University

Email: info@benthamscience.net

References

  1. Poston, J.T.; Koyner, J.L. Sepsis associated acute kidney injury. BMJ, 2019, 364, k4891. doi: 10.1136/bmj.k4891 PMID: 30626586
  2. Shankar-Hari, M.; Phillips, G.S.; Levy, M.L.; Seymour, C.W.; Liu, V.X.; Deutschman, C.S.; Angus, D.C.; Rubenfeld, G.D.; Singer, M. Developing a new definition and assessing new clinical criteria for septic shock. JAMA, 2016, 315(8), 775-787. doi: 10.1001/jama.2016.0289 PMID: 26903336
  3. Ilaria, G.; Kianoush, K.; Ruxandra, B.; Francesca, M.; Mariarosa, C.; Davide, G.; Claudio, R. Clinical adoption of Nephrocheck® in the early detection of acute kidney injury. Ann. Clin. Biochem., 2021, 58(1), 6-15. doi: 10.1177/0004563220970032 PMID: 33081495
  4. Hoste, E.A.J.; Bagshaw, S.M.; Bellomo, R.; Cely, C.M.; Colman, R.; Cruz, D.N.; Edipidis, K.; Forni, L.G.; Gomersall, C.D.; Govil, D.; Honoré, P.M.; Joannes-Boyau, O.; Joannidis, M.; Korhonen, A.M.; Lavrentieva, A.; Mehta, R.L.; Palevsky, P.; Roessler, E.; Ronco, C.; Uchino, S.; Vazquez, J.A.; Vidal Andrade, E.; Webb, S.; Kellum, J.A. Epidemiology of acute kidney injury in critically ill patients: The multinational AKI-EPI study. Intensive Care Med., 2015, 41(8), 1411-1423. doi: 10.1007/s00134-015-3934-7 PMID: 26162677
  5. Peerapornratana, S.; Manrique-Caballero, C.L.; Gómez, H.; Kellum, J.A. Acute kidney injury from sepsis: Current concepts, epidemiology, pathophysiology, prevention and treatment. Kidney Int., 2019, 96(5), 1083-1099. doi: 10.1016/j.kint.2019.05.026 PMID: 31443997
  6. Chen, Y.; Jin, S.; Teng, X.; Hu, Z.; Zhang, Z.; Qiu, X.; Tian, D.; Wu, Y. Hydrogen sulfide attenuates LPS-Induced acute kidney injury by inhibiting inflammation and oxidative stress. Oxid. Med. Cell. Longev., 2018, 2018, 1-10. doi: 10.1155/2018/6717212 PMID: 29636853
  7. Prowle, J.R.; Bellomo, R. Sepsis-associated acute kidney injury: Macrohemodynamic and microhemodynamic alterations in the renal circulation. Semin. Nephrol., 2015, 35(1), 64-74. doi: 10.1016/j.semnephrol.2015.01.007 PMID: 25795500
  8. Hasson, D.C.; Watanabe-Chailland, M.; Romick-Rosendale, L.; Koterba, A.; Miner, D.S.; Lahni, P.; Ma, Q.; Goldstein, S.L.; Devarajan, P.; Standage, S.W. Choline supplementation attenuates experimental sepsis-associated acute kidney injury. Am. J. Physiol. Renal Physiol., 2022, 323(3), F255-F271. doi: 10.1152/ajprenal.00033.2022 PMID: 35834274
  9. Grondman, I.; Pirvu, A.; Riza, A.; Ioana, M.; Netea, M.G. Biomarkers of inflammation and the etiology of sepsis. Biochem. Soc. Trans., 2020, 48(1), 1-14. doi: 10.1042/BST20190029 PMID: 32049312
  10. Gomez, H.; Ince, C.; De Backer, D.; Pickkers, P.; Payen, D.; Hotchkiss, J.; Kellum, J.A. A unified theory of sepsis-induced acute kidney injury: Inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury. Shock, 2014, 41(1), 3-11. doi: 10.1097/SHK.0000000000000052 PMID: 24346647
  11. Toro, J.; Manrique-Caballero, C.L.; Gómez, H Metabolic Reprogramming and Host Tolerance: A Novel Concept to Understand Sepsis-Associated AKI. J. Clin. Med., 2021, 10(18), 4184. doi: 10.3390/jcm10184184
  12. Chen, H.; Busse, L.W. Novel therapies for acute kidney injury. Kidney Int. Rep., 2017, 2(5), 785-799. doi: 10.1016/j.ekir.2017.06.020 PMID: 29270486
  13. Pickkers, P.; Darmon, M.; Hoste, E.; Joannidis, M.; Legrand, M.; Ostermann, M.; Prowle, J.R.; Schneider, A.; Schetz, M. Acute kidney injury in the critically ill: An updated review on pathophysiology and management. Intensive Care Med., 2021, 47(8), 835-850. doi: 10.1007/s00134-021-06454-7 PMID: 34213593
  14. Huang, H.; Ji, L.; Song, S.; Wang, J.; Wei, N.; Jiang, M.; Bai, G.; Luo, G. Identification of the major constituents in Xuebijing injection by HPLC-ESI-MS. Phytochem. Anal., 2011, 22(4), 330-338. doi: 10.1002/pca.1284 PMID: 21500296
  15. Jiang, M.; Zhou, M.; Han, Y.; Xing, L.; Zhao, H.; Dong, L.; Bai, G.; Luo, G. Identification of NF-κB Inhibitors in Xuebijing injection for sepsis treatment based on bioactivity-integrated UPLC-Q/TOF. J. Ethnopharmacol., 2013, 147(2), 426-433. doi: 10.1016/j.jep.2013.03.032 PMID: 23524166
  16. Parker, S.; May, B.; Zhang, C.; Zhang, A.L.; Lu, C.; Xue, C.C. A pharmacological review of bioactive constituents of Paeonia lactiflora Pallas and Paeonia veitchii Lynch. Phytother. Res., 2016, 30(9), 1445-1473. doi: 10.1002/ptr.5653 PMID: 27279421
  17. Yang, X.W.; Li, Y.H.; Zhang, H.; Zhao, Y.F.; Ding, Z.B.; Yu, J.Z.; Liu, C.Y.; Liu, J.C.; Jiang, W.J.; Feng, Q.J.; Xiao, B.G.; Ma, C.G. Safflower Yellow regulates microglial polarization and inhibits inflammatory response in LPS-stimulated Bv2 cells. Int. J. Immunopathol. Pharmacol., 2016, 29(1), 54-64. doi: 10.1177/0394632015617065 PMID: 26634402
  18. Yao, D.; Wang, Z.; Miao, L.; Wang, L. Effects of extracts and isolated compounds from safflower on some index of promoting blood circulation and regulating menstruation. J. Ethnopharmacol., 2016, 191, 264-272. doi: 10.1016/j.jep.2016.06.009 PMID: 27286914
  19. Hong, Q.; Ma, Z.C.; Huang, H.; Wang, Y.G.; Tan, H.L.; Xiao, C.R.; Liang, Q.D.; Zhang, H.T.; Gao, Y. Antithrombotic activities of ferulic acid via intracellular cyclic nucleotide signaling. Eur. J. Pharmacol., 2016, 777, 1-8. doi: 10.1016/j.ejphar.2016.01.005 PMID: 26948317
  20. Zhang, R.; Yu, S.; Bai, H.; Ning, K. TCM-Mesh: The database and analytical system for network pharmacology analysis for TCM preparations. Sci. Rep., 2017, 7(1), 2821. doi: 10.1038/s41598-017-03039-7 PMID: 28588237
  21. Zhou, Z.; Chen, B.; Chen, S.; Lin, M.; Chen, Y.; Jin, S.; Chen, W.; Zhang, Y. Applications of network pharmacology in traditional chinese medicine research. Evid. Based Complement. Alternat. Med., 2020, 2020, 1-7. doi: 10.1155/2020/1646905 PMID: 32148533
  22. Sousa, S.F.; Fernandes, P.A.; Ramos, M.J. Protein-ligand docking: Current status and future challenges. Proteins, 2006, 65(1), 15-26. doi: 10.1002/prot.21082 PMID: 16862531
  23. Manrique-Caballero, C.L.; Del Rio-Pertuz, G.; Gomez, H. Sepsis-associated acute kidney injury. Crit. Care Clin., 2021, 37(2), 279-301. doi: 10.1016/j.ccc.2020.11.010 PMID: 33752856
  24. Ronco, C.; Bellomo, R.; Kellum, J.A. Acute kidney injury. Lancet, 2019, 394(10212), 1949-1964. doi: 10.1016/S0140-6736(19)32563-2 PMID: 31777389
  25. Kellum, J.A.; Romagnani, P.; Ashuntantang, G.; Ronco, C.; Zarbock, A.; Anders, H.J. Acute kidney injury. Nat. Rev. Dis. Primers, 2021, 7(1), 52. doi: 10.1038/s41572-021-00284-z PMID: 34267223
  26. Li, C.; Wang, P.; Zhang, L.; Li, M.; Lei, X.; Liu, S.; Feng, Z.; Yao, Y.; Chang, B.; Liu, B.; Shang, H. Efficacy and safety of Xuebijing injection (a Chinese patent) for sepsis: A metaanalysis of randomized controlled trials. J Ethnopharmacol., 2018, 224, 512-521. doi: 10.1016/j.jep.2018.05.043
  27. Mo, Z.Z.; Lin, Z.X.; Su, Z.R.; Zheng, L.; Li, H.L.; Xie, J.H.; Xian, Y.F.; Yi, T.G.; Huang, S.Q.; Chen, J.P. Angelica sinensis Supercritical Fluid CO 2 extract attenuates D-Galactose-Induced liver and kidney impairment in mice by suppressing oxidative stress and inflammation. J. Med. Food, 2018, 21(9), 887-898. doi: 10.1089/jmf.2017.4061 PMID: 30109956
  28. Chien, L.H.; Wu, C.T.; Deng, J.S.; Jiang, W.P.; Huang, W.C.; Huang, G.J. Salvianolic acid C protects against cisplatin-induced acute kidney injury through attenuation of inflammation, oxidative stress and apoptotic effects and activation of the CaMKK-AMPK-Sirt1-associated signaling pathway in mouse models. Antioxidants, 2021, 10(10), 1620. doi: 10.3390/antiox10101620 PMID: 34679755
  29. Van Doorn, K.J.; Spapen, H.; Geers, C.; Diltoer, M.; Shabana, W. Sepsis-related acute kidney injury: A protective effect of drotrecogin alfa (activated) treatment? Acta Anaesthesiol. Scand., 2008, 52(9), 1259-1264. doi: 10.1111/j.1399-6576.2008.01738.x PMID: 18823466
  30. Wang, Y.; Zhang, H.; Chen, Q.; Jiao, F.; Shi, C.; Pei, M.; Lv, J.; Zhang, H.; Wang, L.; Gong, Z. TNF‐α/HMGB1 inflammation signalling pathway regulates pyroptosis during liver failure and acute kidney injury. Cell Prolif., 2020, 53(6), e12829. doi: 10.1111/cpr.12829 PMID: 32419317
  31. Fatani, S.H.; Alkhatib, K.H.; Badr, H.; ALrefai, A.A. Association of TNF-α-308 (G >A) (rs1800629) Gene Polymorphism with adverse outcomes of Sepsis in critically Ill patients. DNA Cell Biol., 2020, 39(9), 1723-1729. doi: 10.1089/dna.2020.5468 PMID: 32700971
  32. Li, J.; Gui, Y.; Ren, J.; Liu, X.; Feng, Y.; Zeng, Z.; He, W.; Yang, J.; Dai, C. Metformin protects against cisplatin-induced tubular cell apoptosis and acute kidney injury via AMPKα-regulated autophagy induction. Sci. Rep., 2016, 6(1), 23975. doi: 10.1038/srep23975 PMID: 27052588
  33. Zhang, W.; Qi, R.; Li, T.; Zhang, X.; Shi, Y.; Xu, M.; Zhu, T. Kidney organoids as a novel platform to evaluate lipopolysaccharide-induced oxidative stress and apoptosis in acute kidney injury. Front. Med., 2021, 8, 766073. doi: 10.3389/fmed.2021.766073 PMID: 34912825
  34. Ying, J.; Wu, J.; Zhang, Y.; Han, Y.; Qian, X.; Yang, Q.; Chen, Y.; Chen, Y.; Zhu, H. Ligustrazine suppresses renal NMDAR1 and caspase-3 expressions in a mouse model of sepsis-associated acute kidney injury. Mol. Cell. Biochem., 2020, 464(1-2), 73-81. doi: 10.1007/s11010-019-03650-4 PMID: 31732832
  35. Liu, J.; Yang, C.; Zhang, W.; Su, H.; Liu, Z.; Pan, Q.; Liu, H. Disturbance of mitochondrial dynamics and mitophagy in sepsis-induced acute kidney injury. Life Sci., 2019, 235, 116828. doi: 10.1016/j.lfs.2019.116828 PMID: 31479679
  36. Lin, Q.; Li, S.; Jiang, N.; Jin, H.; Shao, X.; Zhu, X.; Wu, J.; Zhang, M.; Zhang, Z.; Shen, J.; Zhou, W.; Gu, L.; Lu, R.; Ni, Z. Inhibiting NLRP3 inflammasome attenuates apoptosis in contrast-induced acute kidney injury through the upregulation of HIF1A and BNIP3-mediated mitophagy. Autophagy, 2021, 17(10), 2975-2990. doi: 10.1080/15548627.2020.1848971 PMID: 33345685
  37. Xu, X.; Wang, J.; Yang, R.; Dong, Z.; Zhang, D. Genetic or pharmacologic inhibition of EGFR ameliorates sepsis-induced AKI. Oncotarget, 2017, 8(53), 91577-91592. doi: 10.18632/oncotarget.21244
  38. Bolisetty, S.; Zarjou, A.; Agarwal, A. Heme oxygenase 1 as a therapeutic target in acute kidney injury. Am. J. Kidney Dis., 2017, 69(4), 531-545. doi: 10.1053/j.ajkd.2016.10.037 PMID: 28139396
  39. Yan, X.; Cheng, X.; He, X.; Zheng, W.; Yuan, X.; Chen, H. HO-1 overexpressed mesenchymal stem cells ameliorate sepsis-associated acute kidney injury by activating JAK/stat3 pathway. Cell. Mol. Bioeng., 2018, 11(6), 509-518. doi: 10.1007/s12195-018-0540-0 PMID: 31719896
  40. Shu, Y.; Yang, Y.; Zhao, Y.; Ma, L.; Fu, P.; Wei, T.; Zhang, L. Melittin inducing the apoptosis of renal tubule epithelial cells through upregulation of Bax/Bcl-2 expression and activation of TNF- α signaling pathway. BioMed Res. Int., 2019, 2019, 1-13. doi: 10.1155/2019/9450368 PMID: 31772938
  41. Yu, W.; Tao, M.; Zhao, Y.; Hu, X.; Wang, M. 4′-Methoxyresveratrol alleviated AGE-induced inflammation via RAGE-mediated NF-κB and NLRP3 inflammasome pathway. Molecules, 2018, 23(6), 1447. doi: 10.3390/molecules23061447 PMID: 29903983

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Bentham Science Publishers